Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Center for Medical Weight Loss (CMWL) vs Spry

vs+10.100000000000009
Spry
Graded #409

Lower grade

The verdict

Center for Medical Weight Loss (CMWL) takes it — 66.9/100 to 56.8/100.

Center for Medical Weight Loss (CMWL) grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Center for Medical Weight Loss (CMWL) runs a 100 percent online, physician-supervised GLP-1 program using compounded semaglutide and tirzepatide with flat any-dose pricing.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueCenter for Medical Weight Loss (CMWL) +22
76
54
Dose & formulationCenter for Medical Weight Loss (CMWL) +8
72
64
Clinical oversightCenter for Medical Weight Loss (CMWL) +23
78
55
Labs & monitoringEven
52
52
FulfillmentCenter for Medical Weight Loss (CMWL) +10
71
61
Contract termsSpry +35
20
55
Center for Medical Weight Loss (CMWL) · left barSpry · right bar

The numbers

MetricCenter for Medical Weight Loss (CMWL)Spry
WeighScore66.9/10056.8/100
GradeCC
Scorecard rank#179#409
Semaglutide$149/mo (all doses, compounded)$199/mo (starting dose, compounded)
Tirzepatide$239/mo (all doses, compounded)$299/mo (starting dose, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only

Strengths

  • Very competitive flat any-dose pricing (semaglutide from 116 dollars per month, tirzepatide from 159 dollars per month)
  • Established Center for Medical Weight Loss brand with physician supervision and clinical support
  • Fast 24-hour approvals and free three to five day shipping

Where it loses points

  • Some states are ineligible and the eligible-state list is not published
  • Compounding pharmacy is not named publicly
  • Lowest per-month prices require a three-month prepaid commitment
Spry

Graded #409 · C

Strengths

  • Three named co-founders disclosed (Gabriel Mullins, Sara Yoder, Tyler Bowman) — better-than-average transparency
  • Pricing shown on the homepage ($199 semaglutide / $299 tirzepatide / $249–$299 peptides) — no full sign-up wall
  • Broader range (2 GLP-1s plus 3 anti-aging peptides) appeals to longevity buyers
  • No contracts or commitment required
  • LegitScript Certified with a public verification link

Where it loses points

  • Displays an "FDA Approved" badge though compounded GLP-1s are not FDA-approved finished drugs — potentially misleading
  • Intake reviewed by a nurse practitioner, not an MD
  • States served not disclosed publicly
  • Pharmacy partner not named, and 503A vs 503B designation not specified
  • FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard